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GENOTYPE AND NATURAL HISTORY IN 
UNRELATED INDIVIDUALS WITH 
PHENYLKETONURIA AND AUTISTIC BEHAVIOR
Carlos Eduardo Steiner1, Angelina Xavier Acosta2,
Marilisa Mantovani Guerreiro3, Antonia Paula Marques-de-Faria1
ABSTRACT - We describe three unrelated individuals, two males (ages 35 and 9) and a female (age 8) pre-
senting with late diagnosed phenylketonuria (PKU) and autistic behavior, all showing poor adhesion to
the dietary treatment resulting in high plasmatic phenylalanine levels, particularly in the oldest subject.
Clinical findings included hair hypopigmentation, micro c e p h a l y, severe mental re t a rdation with absent
development of verbal language and autistic symptoms in all three patients, whereas variable neurolog-
ical signs such as seizures, spasticity, ataxia, aggre s s i v i t y, and hyperactivity were individually found.
Homozygosity for the IVS10nt11g/a (IVS10nt546) was found in all. This is the first re p o rt of molecular find-
ings in subjects with PKU also presenting with autistic features. The authors discuss if this mutation is par-
ticularly involved in the association of autistic symptoms in untreated PKU individuals.
KEY WORDS: autism, natural history, pervasive developmental disorders, phenylalanine hydro x i l a s e ,
phenylketonuria.
Genótipo e história natural em indivíduos não aparentados com fenilcetonúria e comport a m e n-
to autístico
RESUMO - Descrevemos três indivíduos não aparentados, dois do sexo masculino (com idades de 35 e nove
anos) e um do sexo feminino (com idade de oito anos) apresentando fenilcetonúria diagnosticada tard i a-
mente e comportamento autístico, todos com adesão limitada ao tratamento dietético resultando em altos
níveis plasmáticos de fenilalanina, especialmente no indivíduo mais velho. Os achados clínicos incluem
hipopigmentação de cabelos, retardo mental grave com ausência de desenvolvimento da linguagem ver-
bal e sintomas autísticos nos três pacientes, enquanto outros achados neurológicos como convulsões, espas-
ticidade, ataxia, agressividade e hiperatividade são descritos em um indivíduo, cada. Homozigose para a
mutação IVS10nt11g/a (IVS10nt546) foi encontrada em todos. Este é o primeiro relato de achados molecu-
l a res em indivíduos com fenilcetonúria que desenvolveram características autísticas. Discute-se se essa
mutação estaria part i c u l a rmente envolvida no desenvolvimento de sintomas autísticos em indivíduos com
fenilcetonúria não tratada.
PA L AV R A S - C H AVE: autismo, história natural, distúrbios invasivos do desenvolvimento, hidroxilase de feni-
lalanina, fenilcetonúria.
Autism is a behavioral syndrome with still poorly
understood etiologies. In most cases, it is pro b a b l y
caused by multifactorial inheritance that means the
association of genetic factors to environmental fac-
tors. On the other hand, in 10 to 20% of all cases a
specific cause can be determined, including chro m o-
somal abnorm a l i t i e s1, metabolic disord e r s2, mono-
genic conditions like tuberous sclerosis, fragile X syn-
d rome or other entities, as well as “pure” enviro n-
mental factors3.
C o n c e rning the metabolic disorders, phenylke-
tonuria (PKU) was frequently associated with autis-
tic symptoms. This association has almost vanished
since the introduction of early detection and tre a t-
ment for phenylalanine hydroxilase (PAH) deficien-
c y. However, even in countries where newborn scre e n-
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ing is available, one may miss the diagnosis for sev-
eral reasons, including births outside hospitals, too
early screening, samples mismatches or false nega-
tive re s u l t s4. Thus, phenylketonuric individuals pre-
senting with neurological impairments including
autistic behavior still occur.
To date, no information on the molecular basis
has been reported in individuals with autistic symp-
toms due to PKU. The present study describes clini-
cal and molecular findings in three unrelated patients
with this association.
METHOD
T h ree unrelated individuals were evaluated. The fi rst
patient was re f e rred with a previous diagnosis of PKU while
autistic symptoms were diagnosed during clinical assess-
ment. The remaining two patients were enrolled in a more
c o m p rehensive study on 84 individuals with pervasive devel-
opmental disord e r s5; PKU was previously known in one sub-
ject and was diagnosed by laboratory tests in the other.
I n f o rmed consent for the clinical and molecular study
was obtained from parents in all three cases after appro v a l
of the Ethics Review Board, FCM/Unicamp.
Individuals and close relatives underwent molecular
analysis of the PAH gene in the following protocol: DNA
was isolated from leukocytes of each subject by standard
m e t h o d s6 and analyzed for mutations by PCR amplification
of the 13 segments comprising the entire coding sequence,
splicing functions and the promoter region of the PA H
gene, followed by DGGE7 and sequencing8. When DGGE
analysis of exon 11 of the PAH gene revealed an abnorm a l
p a t t e rn for the patients suggesting the IVS10nt-11g/a
(IVS10nt546) mutation, gene sequencing was also per-
formed to confirm this finding.
Clinical reports
Patient 1 – Male, 35 years old, 10t h child of consan-
guineous parents (first-cousins) of Portuguese origin and
p roceeding from the State of Paraná in South Brazil. An
oldest sister died at the age of two years by a “mental dis-
o rder”. The family history is otherwise unremarkable. Pre g-
nancy was uncomplicated. Delivery was at home, with no
medical assistance. At the tim e of his birth, in the 1960’ s ,
t h e re was no neonatal metabolic screening in Brazil. His
n e u romotor development was globally delayed and at the
age of four he was diagnosed as having PKU by Guthrie
bacterial inhibition assays in urinary samples. The family
was then oriented to follow dietary treatment with low
p rotein intake, which was perf o rmed for three years. Since
t h e re was no improvement of the neurological impairm e n t ,
the diet was interrupted. There was psychomotor delay
with no language development and he could never be toi-
let trained. At the age of 12 he started to present auto-
aggressivity. There was no history of seizures.
In his first clinical assessment at the age of 35, his stature
was 168 cm (25t h centile), weight 58 kg (25t h centile), and
OFC 53 cm (3rd centile). He was not collaborative for a
detailed evaluation but there were no relevant dysmorphic
features, except for an extensive pilous nevus on the dor-
sum and left arm. His hair and beard were red, diff e re n t
f rom the dark haired familial pattern. There were multiple
scars over the scalp caused by repetitive head hitting against
the wall and callosities over the dorsum of the hands fro m
self-biting. He did not collaborate with neurological exam-
ination but he was noted to present spasticity in the upper
members. He avoided eye contact and did not use verbal
or gesture language, most of the time presenting body-
shaking and worm-like movements of the fingers, as well
as a frequent unintelligible mumbling or “singing”. There
was a significant impairment in social interaction with oth-
er family members and strangers manifested as failure in
developing peer relationships and lack of emotional re c i-
p ro c i t y, becoming auto and hetero - a g g ressive every time
someone approached him. There was also adherence to ali-
m e n t a ry routines and inflexibility in dealing with enviro n-
mental changes. Thus, he fulfilled DSM-IV criteria for autism.
A first plasmatic phenylalanine measure resulted 48.5
mg% for a re f e rence value of up to 4 mg%. Dietary tre a t-
ment was reintroduced with the assistance of a nutrition-
ist. The family re p o rted some improvement in behavior,
a g g ressivity and sleep. Unfortunately the patient manifest-
ed high resistance to this diet resulting in a weight lost of
3 kg in a few weeks. The plasmatic phenylalanine levels
never fall bellow 17 mg% during this time. Less than one
year after reintroducing treatment, the family decided to
definitely interrupt it.
Chromosomal analysis in lymphocytes with G-banding
technique and a resolution of 400 bands resulted in a 46,XY
normal male constitution. A brain single photon emission
computed tomography (brain SPECT) with Tc9 9, which
revealed heterogeneous distribution of the radiopharm a c
in the whole cerebral cortex, thus suggesting diffuse brain
damage.
Molecular analysis of the PAH gene revealed homozy-
gosity for the IVS10nt-11g/a mutation. The father and one
sister were heterozygous for the same mutation and two
u n a ffected sisters were heterozygous for the L385L substi-
tution. The mother was deceased and no molecular test
could be perf o rmed but most probably she was a double
h e t e rozygous for the IVS10nt-11g/a mutation and the L385L
polymorphism.
Patient 2 – Male, nine years old, the first child of a cou-
ple of Portuguese and Amerindian ancestry pro c e e d i n g
from the State of Paraíba in Northeastern Brazil. The par-
ents denied consanguinity but they were both born in a
small village with 10,000 inhabitants according to the Bra-
zilian populational census in 2000. The family history is oth-
e rwise unremarkable. Pregnancy and delivery were uncom-
plicated and he was born at term, weighting 2.8 kg and
measuring 47 cm. Neonatal screening was not perf o rm e d .
His development was globally delayed and he never ac-
q u i red verbal language. At the age of five, he started to
p resent tonic-clonic seizures with good response to phe-
nobarbital. Besides severe impairment of verbal and non-
verbal skills, he avoided physical contact with strangers,
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had no adequate peer relationships, used to treat persons
as objects, and had abnormal interest on bicycle wheels,
water and puzzles small pieces. He also presented hand
and head shaking stereotyped movements. At the age of
six, he was sent to a school for autistic children.
When the youngest sis ter was born, neonatal scre e n-
ing was perf o rmed and a diagnosis of hyperphenylalanine-
mia was established. She was adequately managed since
then and presents normal somatic and neurological devel-
opments. Because of her neonatal screening, a diagnosis
of PKU was investigated and confirmed in patient 2 and
d i e t a rytreatment was introduced at the age of five w ith
some behavioral improvement. Despite that, the family was
unable to keep a rigid diet and at the age of nine he
showed high phenylalanine plasmatic levels, with values
around 18 mg% in several consecutive measurements.
At the first clinical evaluation, he presented norm a l
weight and stature with an OFC of 50 cm (3rd centile). There
w e re no relevant dysmorphic features. The patient pre s e n t-
ed brown hair, contrasting with the dark haired family pat-
t e rn. Neurological assessment revealed intermittent eye
contact, inadequate answers to simple questions, hyperac-
tivity and stereotyped movements like hand flapping and
head shaking. There was no abnormal muscular tonus or
other neurological signs. He fulfilled DSM-IV criteria for
typical autistic disorder.
Other complementary tests included chro m o s o m a l
analysis in lymphocytes with G-banding technique and a
resolution of 400 bands (46,XY), molecular analysis for the
FRAXA, FRAXE and FRAXF mutations (negative) and a brain
computed tomography which revealed widening of the lat-
eral ventricles, suggesting mild ex vacuum hydrocephaly.
Molecular analysis of the PAH gene revealed homozy-
gosity for the IVS10nt-11g/a mutation in the patient and
the younger sister. Parents were heterozygous for the same
mutation and the unaffected sister showed homozygosity
for the normal allele.
Patient 3 – Female, eight years old, the second child of
a consanguineous couple (first cousins) of Portuguese ori-
gin proceeding from the State of São Paulo in Southeastern
Brazil. Pregnancy was uncomplicated. Delivery was at term ,
weighting 3.3 kg and measuring 49 cm. Apgar scores were
9 and 10. Neonatal screening was not perf o rmed. Develop-
ment was globally delayed and she never acquired verbal
language. At the age of 15 months, she presented myo-
clonic seizures with spontaneous resolution. She attends a
school for autistic children since the second year of life.
At the first clinical assessment, she presented norm a l
weight and stature with an OFC of 49 cm (3rd centile). Dys-
morphologic evaluation revealed thin habitus, prominent
upper central incisors and mild cubitus valgus, which where
p resent in the mother and considered familial feature s
without other clinical significance. She also presented bro w n
h a i r, diff e rent from the dark haired family pattern. The
n e u rological evaluation revealed hyperactivity, ataxic gait,
dysmetria, intention tremors of the upper extremities and
flapping. She did not interact with other children and pre-
sented rigid routines and abnormal interest for ro t a t o ry
objects such as wheels or blenders. She fulfilled DSM-IV cri-
teria for typical autistic disorder.
During the laboratory investigation, an amino acid chro-
matography revealed increased phenylalanine in urine sam-
ples. A plasmatic phenylalanine measure at this age re s u l t-
ed 19.6 mg%. Dietary treatment was introduced with some
behavioral improvement after a few months.
Other complementary tests included chromosomal anal-
ysis in lymphocytes with G-banding technique and a reso-
lution of 400 bands (46,XX), molecular analysis for the
FRAXA, FRAXE and FRAXF mutations (negative), EEG (dif-
fuse epileptic activity in both cerebral hemispheres) and a
brain SPECT (normal). Molecular analysis of the PAH gene
revealed homozygosity for the IVS10nt-11g/a mutation.
DISCUSSION
Since the description of PKU in 1934 by Fölling9,
several authors, mainly from the earlier medical litera-
t u re, re p o rted individuals with autism and PKU1 0 - 1 7.
This issue has been previously re v i e w e d1 0 , 1 8. Most
authors did not specify diagnostic criteria for autism
and to date no information on the PAH mutation(s)
has been provided in such cases. In this re p o rt, the
IVS10nt11g/a mutation was found in three unre l a t-
ed individuals. It consists in a single base substitution
that creates a novel splice site in intron 10, causing
a b e rrant splicing and the addition of nine nucleotides
c o rresponding to three extra amino acids (Gly-Leu-
Gln) between the normal sentences of intron 10 and
i n t ron 11. This change is incompatible with the stru c-
tural maintenance of arc h i t e c t u re of the PAH pro-
tein which can be detected in normal amounts but
shows no activity. The resulting phenotype is of severe
phenylalanine intolerance and classical PKU19.
The IVS10nt11g/a is the most common molecular
defect of the PAH gene causing PKU in Mediter-
ranean populations. It seems to be originated in the
Turkey-Israel area and introduced in Italy and in the
Iberian Peninsula due to gene flow2 0. The migratory
events from the 16t h c e n t u ry introduced the muta-
tion in Brazil2 1, as well as in Chile, Argentina, and
M e x i c o2 2. The L385L polymorphism, detected in fam-
ily 1, is also common in the Portuguese population2 3.
In Brazil, gene frequencies for the PAH mutations
varies in each State and region, also as a consequence
of the migratory flow. For this reason, the IVS10nt
11g/a is rare (2.4% of the allele frequency) in South-
e rn Brazil2 1, where a significant part of the popula-
tion descends from immigrants of Central Euro p e a n
countries. On the other hand, this mutation is the
most prevalent (17.4%) in the State of São Paulo8,
where the influence of Portuguese, Spanish, Greek,
Lebanese, Turkish, and Jewish immigrants is gre a t .
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An allele frequency of up to 20% for this mutation
was also found in the Nort h e a s t e rn Brazilian popu-
l a t i o n2 4, where Portuguese and Afro-Brazilians re p-
resent the most frequent ethnic background of its
population.
It is interesting to note that many individuals with
u n t reated PKU who developed autism came the
M e d i t e rranean area and countries that received immi-
grants from this region: Italy1 4 , 1 7, Tu n i s1 5, and Ve n e-
z u e l a1 6, although molecular findings were not re p o rt-
ed by these authors. This raises the possibility that a
few or even one specific mutation could be associat-
ed with autism in individuals with PKU. Our re s u l t s
suggest that the IVS10nt-11g/a could be this muta-
tion or at least one of them.
A confinable percentage of patients with PKU
having autistic symptomatology is difficult to deter-
mine, specially after introduction of treatment. In
1975, Knobloch and Pasamanick25 found 14 (21.8%)
phenylketonuric individuals among 64 patients with
autism diagnosed by Kanner criteria, which may be
an overestimation. More re c e n t l y, we found two sub-
jects with PKU (present patients 2 and 3) in a sample
of 84 individuals with pervasive developmental dis-
o rders diagnosed by DSM-IV criteria, giving a fre-
quency of 2.3% in the total sample comprising all
PDDs or 2.7% if Asperger syndrome was excluded
and only autism, either typical or atypical, was con-
s i d e re d5. On the other way, Baieli et al.1 7 re p o rted 35
individuals with classic PKU late diagnosed, all with
mental re t a rdation and two (5.7%) presenting autism
based on the Autistic Diagnostic Interview Revised
(ADI-R) and the Childhood Autism Rating Scale (CARS)
criteria.
In conclusion, the present study re p o rts three un-
related individuals presenting with PKU and autistic
f e a t u res diagnosed by DSM-IV criteria. It is the first
work to describe the molecular findings in such cas-
es. All three individuals were homozygous for the
IVS10nt-11g/a raising the question whether this muta-
tion could be associated with the development of
autistic symptoms in untreated individuals.
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